首页> 外文期刊>Cancer biology & therapy >Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
【24h】

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice

机译:裸鼠异种移植模型中人三阴性乳腺癌细胞株发展至淋巴结转移过程中的蛋白表达变化

获取原文
获取原文并翻译 | 示例
       

摘要

Triple negative breast cancers (TNBC) lacking hormone receptors and HER-2 amplification are very aggressive tumors. Since relevant differences between primary tumors and metastases could arise during tumor progression as evidenced by phenotypic discordances reported for hormonal receptors or HER-2 expression, in this analysis we studied changes that occurred in our TNBC model IIB-BR-G throughout the development of IIB-BR-G- MTS6 metastasis to the lymph nodes (LN) in nude mice, using an antibody-based protein array to characterize their expression profile. We also analyzed their growth kinetics, migration, invasiveness and cytoskeleton structure in vitro and in vivo. In vitro IIB-BR-G- MTS6 cells grew slower but showed higher anchorage independent growth. In vivo IIB-BR-G- MTS6 tumors grew significantly faster and showed a 100% incidence of LN metastasis after s.c. inoculation, although no metastasis was observed for IIB-BR-G. CCL3, IL1β, CXCL1, CSF2, CSF3, IGFBP1, IL1α, IL6, IL8, CCL20, PLAUR, PlGF and VEGF were strongly upregulated in IIB-BR-G- MTS6 while CCL4, ICAM3, CXCL12, TNFRSF18, FIGF were the most downregulated proteins in the metastatic cell line. IIB-BR-G- MTS6 protein expression profile could reflect a higher NFκB activation in these cells. In vitro, IIB-BR-G displayed higher migration but IIB-BR-G- MTS6 had more elevated matrigel invasion ability. In agreement with that observation, IIB-BR-G- MTS6 had an upregulated expression of MMP1, MMP9, MMP13, PLAUR and HGF. IIB-BR-G- MTS6 tumors presented also higher local lymphatic invasion than IIB-BR-G but similar lymphatic vessel densities. VEGFC and VEGFA/B expression were higher both in vitro and in vivo for IIB-BR-G- MTS6. IIB-BR-G- MTS6 expressed more vimentin than IB-BR-G cells, which was mainly localized in the cellular extremities and both cell lines are E-cadherin negative. Our results suggest that IIB-BR-G- MTS6 cells have acquired a pronounced epithelial-to-mesenchymal transition phenotype. Protein expression changes observed between primary tumor-derived IIB-BR-G and metastatic IIB-BR-G- MTS6 TNBC cells suggest potential targets involved in the control of metastasis.
机译:缺乏激素受体和HER-2扩增的三阴性乳腺癌(TNBC)是非常侵袭性的肿瘤。正如报道的激素受体或HER-2表达的表型不一致所表明的那样,由于在肿瘤进展过程中可能会发生原发肿瘤和转移瘤之间的相关差异,因此在此分析中,我们研究了在整个IIB发展过程中TNBC IIB-BR-G模型发生的变化-BR-G- MTS6转移至裸鼠的淋巴结(LN),使用基于抗体的蛋白质阵列表征其表达特征。我们还分析了它们在体外和体内的生长动力学,迁移,侵袭性和细胞骨架结构。体外IIB-BR-G-MTS6细胞生长较慢,但显示出较高的锚定非依赖性生长。体内IIB-BR-G-MTS6肿瘤生长较快,在s.c.后显示LN转移的发生率100%。接种,尽管没有观察到IIB-BR-G有转移。 CCL3,IL1β,CXCL1,CSF2,CSF3,IGFBP1,IL1α,IL6,IL8,CCL20,PLAU,PlGF和VEGF在IIB-BR-G-MTS6中被上调,而CCL4,ICAM3,CXCL12,TNFRSF18,FIGF被下调最多转移细胞系中的蛋白质。 IIB-BR-G-MTS6蛋白表达谱可能反映了这些细胞中更高的NFκB活化。在体外,IIB-BR-G显示出更高的迁移,但是IIB-BR-G-MTS6具有更高的基质胶侵袭能力。与该观察结果一致,IIB-BR-G-MTS6具有MMP1,MMP9,MMP13,PLAUR和HGF的表达上调。 IIB-BR-G-MTS6肿瘤也比IIB-BR-G表现出更高的局部淋巴管浸润,但淋巴管密度相似。对于IIB-BR-G-MTS6,VEGFC和VEGFA / B的表达在体外和体内均较高。 IIB-BR-G-MTS6表达的波形蛋白比IB-BR-G细胞更多,其主要定位在细胞末端,并且两个细胞系均为E-钙粘蛋白阴性。我们的结果表明IIB-BR-G-MTS6细胞已经获得了明显的上皮-间充质转化表型。在原发性肿瘤来源的IIB-BR-G和转移性IIB-BR-G-MTS6 TNBC细胞之间观察到的蛋白表达变化表明潜在的靶标参与了转移的控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号